Anest. intenziv. Med. 2000;11(6):259-261

Bupivacaine versus Bupivacaine-fentanyl in Brachial Plexus Block for Postoperative AnalgesiaArticles

I. Przewłocki, M. Májek, V. Przewłocka
KAIM, Fakultná NsP ak. L. Dérera, Bratislava, vedúci doc. MUDr. M. Májek, CSc.

Analgetic effect of plain bupivacaine 0.2% vs. bupivacaine-fentanyl was assessed in brachial plexus block. In the first group, thirty millilitres ofbupivacaine 0.2% with fentanyl 3 mg/ml were administered via the catheter every 8 hours; the other group received bupivacaine 0.2% in the sameregimen. Analgesia was assessed according to visual analogue pain score (VAPS) during 72-hour postoperative period. Significantly better analgesiawas achieved in bupivacaine-fentanyl group starting postoperative hour 9, in spite of higher supplemental doses of analgetics in the non-fentanyl group.From the results we can draw a conclusion that fentanyl addition to analgetic concentration of bupivacaine for brachial plexus block is warranted.The quality of analgesia produced is better, requiring for less supplemental doses of other analgetics.

Keywords: postoperative regional analgesia; fentanyl; bupivacaine

Published: December 1, 2000  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Przewłocki I, Májek M, Przewłocka V. Bupivacaine versus Bupivacaine-fentanyl in Brachial Plexus Block for Postoperative Analgesia. Anest. intenziv. Med. 2000;11(6):259-261.
Download citation




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.